Jasper Therapeutics, Inc. (JSPR)

Jasper Therapeutics Statistics

Total Valuation

JSPR has a market cap or net worth of $44.35 million. The enterprise value is -$4.98 million.

Market Cap	44.35M
Enterprise Value	-4.98M

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

JSPR has 27.98 million shares outstanding. The number of shares has increased by 15.70% in one year.

Current Share Class	27.98M
Shares Outstanding	27.98M
Shares Change (YoY)	+15.70%
Shares Change (QoQ)	+8.49%
Owned by Insiders (%)	1.19%
Owned by Institutions (%)	61.86%
Float	23.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.82
P/TBV Ratio	3.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.15.

Current Ratio	2.59
Quick Ratio	2.42
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -191.12% and return on invested capital (ROIC) is -115.53%.

Return on Equity (ROE)	-191.12%
Return on Assets (ROA)	-72.92%
Return on Invested Capital (ROIC)	-115.53%
Return on Capital Employed (ROCE)	-251.24%
Revenue Per Employee	n/a
Profits Per Employee	-$1.42M
Employee Count	64
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -93.78% in the last 52 weeks. The beta is 3.06, so JSPR's price volatility has been higher than the market average.

Beta (5Y)	3.06
52-Week Price Change	-93.78%
50-Day Moving Average	2.13
200-Day Moving Average	3.75
Relative Strength Index (RSI)	31.93
Average Volume (20 Days)	3,577,834

Short Selling Information

The latest short interest is 1.51 million, so 5.39% of the outstanding shares have been sold short.

Short Interest	1.51M
Short Previous Month	1.53M
Short % of Shares Out	5.39%
Short % of Float	6.42%
Short Ratio (days to cover)	3.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-91.52M
Pretax Income	-91.02M
Net Income	-91.02M
EBITDA	-90.51M
EBIT	-91.52M
Earnings Per Share (EPS)	-$5.79

Balance Sheet

The company has $50.90 million in cash and $1.70 million in debt, giving a net cash position of $49.20 million or $1.76 per share.

Cash & Cash Equivalents	50.90M
Total Debt	1.70M
Net Cash	49.20M
Net Cash Per Share	$1.76
Equity (Book Value)	11.57M
Book Value Per Share	0.41
Working Capital	33.52M

Cash Flow

In the last 12 months, operating cash flow was -$76.43 million and capital expenditures -$103,000, giving a free cash flow of -$76.53 million.

Operating Cash Flow	-76.43M
Capital Expenditures	-103,000
Free Cash Flow	-76.53M
FCF Per Share	-$2.73

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JSPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.70%
Shareholder Yield	-15.70%
Earnings Yield	-205.86%
FCF Yield	-173.09%

Analyst Forecast

The average price target for JSPR is $25.60, which is 1,515.14% higher than the current price. The consensus rating is "Buy".

Price Target	$25.60
Price Target Difference	1,515.14%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-24.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 4, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Jan 4, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1